A novel, antibody-based radiopharmaceutical for advanced thyroid cancer
– Published 25 May 2022
In collaboration with Assoc. Prof Marika Nestor (Uppsala University) the facilities of SciLifeLab's Drug Discovery and Development Platform, including the Human Antibody Therapeutics unit at the Dept. of Immunotechnology, have co-developed an antibody-based radiopharmaceutical intended for treatment of advanced thyroid cancer. The project now exits the SciLifeLab infrastructure environment for further commercial development.